Efficacy of Antivascular Ultrasound (AVUS) in Hepatocellular Carcinoma (HCC)
AVUS is a promising novel treatment modality for HCC. Current evidence suggests that AVUS exhibits a dose-dependent nature, making it a versatile approach that can be effectively combined with other therapeutic regimens. Further clinical studies and long-term follow-ups are needed to establish the optimal clinical protocol and safety profile of AVUS.
Authors
- Fereshteh Yazdanpanah (ORCID: https://orcid.org/0000-0002-0221-346X)
- Chandra M. Sehgal (ORCID: https://orcid.org/0000-0002-8811-1930)
- Zhuorui Li (ORCID: https://orcid.org/0000-0003-1989-1862)
- Aashish Cheruvu
- Moein Moradpour (ORCID: https://orcid.org/0000-0003-4003-9324)
- Omar Al‐Daoud
- Stephen Hunt
Institutions
- Hospital of the University of Pennsylvania (US)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-07
- DOI
- https://doi.org/10.3390/cancers16223756
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.37